Elbit Imaging Ltd. (EMITF)
USD 1.2
(0.0%)
USD 1.2
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 328 Thousand ILS | 0.0% |
| 2022 | - ILS | 0.0% |
| 2021 | - ILS | 0.0% |
| 2020 | - ILS | 0.0% |
| 2019 | - ILS | 0.0% |
| 2018 | - ILS | 100.0% |
| 2017 | -22.79 Million ILS | -71.19% |
| 2016 | -13.31 Million ILS | 80.77% |
| 2015 | -69.24 Million ILS | -3.04% |
| 2014 | -67.2 Million ILS | 21.58% |
| 2013 | -85.69 Million ILS | -312.4% |
| 2012 | 40.34 Million ILS | -78.24% |
| 2011 | 185.38 Million ILS | -72.06% |
| 2010 | 663.55 Million ILS | 2264.95% |
| 2009 | -30.65 Million ILS | -122.34% |
| 2008 | 137.19 Million ILS | -89.51% |
| 2007 | 1.3 Billion ILS | 46.24% |
| 2006 | 893.96 Million ILS | 194.79% |
| 2005 | 303.25 Million ILS | 74.31% |
| 2004 | 173.97 Million ILS | -0.54% |
| 2003 | 174.92 Million ILS | 19.95% |
| 2002 | 145.82 Million ILS | 33.62% |
| 2001 | 109.13 Million ILS | 45.67% |
| 2000 | 74.92 Million ILS | 109.73% |
| 1999 | 35.72 Million ILS | 8486.03% |
| 1998 | 416.05 Thousand ILS | -99.94% |
| 1997 | 679.45 Million ILS | -1.29% |
| 1996 | 688.37 Million ILS | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | - ILS | 0.0% |
| 2024 Q1 | - ILS | -100.0% |
| 2023 FY | 328 Thousand ILS | 0.0% |
| 2023 Q2 | - ILS | 0.0% |
| 2023 Q1 | - ILS | 0.0% |
| 2023 Q4 | 164 Thousand ILS | 0.0% |
| 2023 Q3 | 164 Thousand ILS | 0.0% |
| 2022 FY | - ILS | 0.0% |
| 2022 Q1 | - ILS | 0.0% |
| 2022 Q4 | - ILS | 0.0% |
| 2022 Q3 | - ILS | 0.0% |
| 2022 Q2 | - ILS | 0.0% |
| 2021 Q4 | - ILS | 0.0% |
| 2021 Q1 | - ILS | 0.0% |
| 2021 Q3 | - ILS | 0.0% |
| 2021 Q2 | - ILS | 0.0% |
| 2021 FY | - ILS | 0.0% |
| 2020 Q1 | - ILS | 0.0% |
| 2020 Q4 | - ILS | 0.0% |
| 2020 FY | - ILS | 0.0% |
| 2020 Q3 | - ILS | 0.0% |
| 2020 Q2 | - ILS | 0.0% |
| 2019 Q3 | - ILS | 0.0% |
| 2019 Q1 | - ILS | 0.0% |
| 2019 Q2 | - ILS | 0.0% |
| 2019 Q4 | - ILS | 0.0% |
| 2019 FY | - ILS | 0.0% |
| 2018 Q2 | -2.96 Million ILS | 0.0% |
| 2018 Q1 | -2.96 Million ILS | 99.33% |
| 2018 FY | - ILS | 100.0% |
| 2018 Q4 | - ILS | -100.0% |
| 2018 Q3 | 6.01 Million ILS | 303.04% |
| 2017 FY | -22.79 Million ILS | -71.19% |
| 2017 Q4 | -443.28 Million ILS | 0.0% |
| 2017 Q1 | 6.74 Million ILS | 178.62% |
| 2017 Q2 | 6.74 Million ILS | 0.0% |
| 2017 Q3 | -443.28 Million ILS | -6675.44% |
| 2016 Q3 | -147 Thousand ILS | -102.69% |
| 2016 Q4 | -8.57 Million ILS | -5733.33% |
| 2016 FY | -13.31 Million ILS | 80.77% |
| 2016 Q1 | -10.06 Million ILS | 97.1% |
| 2016 Q2 | 5.47 Million ILS | 154.36% |
| 2015 FY | -69.24 Million ILS | -3.04% |
| 2015 Q3 | -7.9 Million ILS | 83.02% |
| 2015 Q2 | -46.54 Million ILS | -220.22% |
| 2015 Q4 | -346.75 Million ILS | -4287.03% |
| 2015 Q1 | -14.53 Million ILS | 96.53% |
| 2014 Q4 | -418.94 Million ILS | -2233.15% |
| 2014 FY | -67.2 Million ILS | 21.58% |
| 2014 Q2 | -8.65 Million ILS | 59.91% |
| 2014 Q3 | -17.95 Million ILS | -107.54% |
| 2014 Q1 | -21.58 Million ILS | -32.97% |
| 2013 Q3 | -24.06 Million ILS | -38.08% |
| 2013 FY | -85.69 Million ILS | -312.4% |
| 2013 Q4 | -16.23 Million ILS | 32.56% |
| 2013 Q1 | 8.75 Million ILS | 184.89% |
| 2013 Q2 | -17.43 Million ILS | -299.17% |
| 2012 Q3 | 11.75 Million ILS | 139.53% |
| 2012 Q4 | -10.31 Million ILS | -187.71% |
| 2012 Q2 | -29.73 Million ILS | -113.5% |
| 2012 FY | 40.34 Million ILS | -78.24% |
| 2012 Q1 | 220.23 Million ILS | 537.47% |
| 2011 Q1 | 39.55 Million ILS | -85.14% |
| 2011 Q2 | 45.1 Million ILS | 14.04% |
| 2011 Q3 | 66.18 Million ILS | 46.72% |
| 2011 Q4 | 34.54 Million ILS | -47.8% |
| 2011 FY | 185.38 Million ILS | -72.06% |
| 2010 Q4 | 266.1 Million ILS | 967.67% |
| 2010 FY | 663.55 Million ILS | 2264.95% |
| 2010 Q1 | -24.62 Million ILS | 34.06% |
| 2010 Q2 | 397.14 Million ILS | 1712.78% |
| 2010 Q3 | 24.92 Million ILS | -93.72% |
| 2009 Q3 | -22.91 Million ILS | -114.53% |
| 2009 FY | -30.65 Million ILS | -122.34% |
| 2009 Q1 | 47.31 Million ILS | -17.82% |
| 2009 Q2 | 157.66 Million ILS | 233.26% |
| 2009 Q4 | -37.34 Million ILS | -62.96% |
| 2008 Q1 | 34.81 Million ILS | -96.8% |
| 2008 Q2 | 88.06 Million ILS | 152.93% |
| 2008 Q3 | -44.21 Million ILS | -150.2% |
| 2008 FY | 137.19 Million ILS | -89.51% |
| 2008 Q4 | 57.56 Million ILS | 230.21% |
| 2007 Q4 | 1.08 Billion ILS | 3201.05% |
| 2007 FY | 1.3 Billion ILS | 46.24% |
| 2007 Q3 | 32.96 Million ILS | -57.89% |
| 2007 Q2 | 78.28 Million ILS | 157.71% |
| 2007 Q1 | 30.37 Million ILS | -96.15% |
| 2006 Q1 | 48.7 Million ILS | -41.12% |
| 2006 FY | 893.96 Million ILS | 194.79% |
| 2006 Q3 | 54.89 Million ILS | 270.12% |
| 2006 Q4 | 787.99 Million ILS | 1335.49% |
| 2006 Q2 | 14.83 Million ILS | -69.55% |
| 2005 FY | 303.25 Million ILS | 74.31% |
| 2005 Q2 | 47.22 Million ILS | 54.51% |
| 2005 Q1 | 30.56 Million ILS | -17.77% |
| 2005 Q4 | 82.7 Million ILS | -48.2% |
| 2005 Q3 | 159.65 Million ILS | 238.09% |
| 2004 Q1 | 156.52 Million ILS | 199.33% |
| 2004 Q2 | 61.39 Million ILS | -60.78% |
| 2004 Q3 | 23.85 Million ILS | -61.14% |
| 2004 Q4 | 37.16 Million ILS | 55.8% |
| 2004 FY | 173.97 Million ILS | -0.54% |
| 2003 FY | 174.92 Million ILS | 19.95% |
| 2003 Q3 | 53.82 Million ILS | 48.3% |
| 2003 Q1 | 37.16 Million ILS | -6.62% |
| 2003 Q2 | 36.29 Million ILS | -2.34% |
| 2003 Q4 | 52.29 Million ILS | -2.85% |
| 2002 Q4 | 39.79 Million ILS | -0.81% |
| 2002 Q1 | 38.13 Million ILS | 23.82% |
| 2002 Q2 | 56.94 Million ILS | 49.32% |
| 2002 FY | 145.82 Million ILS | 33.62% |
| 2002 Q3 | 40.12 Million ILS | -29.55% |
| 2001 Q2 | 148.11 Million ILS | 533.13% |
| 2001 FY | 109.13 Million ILS | 45.67% |
| 2001 Q4 | 30.8 Million ILS | 16.77% |
| 2001 Q3 | 26.37 Million ILS | -82.19% |
| 2001 Q1 | 23.39 Million ILS | -5.94% |
| 2000 Q2 | 18.7 Million ILS | 43.95% |
| 2000 Q1 | 12.99 Million ILS | -82.9% |
| 2000 Q3 | 13.86 Million ILS | -25.89% |
| 2000 FY | 74.92 Million ILS | 109.73% |
| 2000 Q4 | 24.87 Million ILS | 79.42% |
| 1999 Q3 | 86.3 Million ILS | 4.75% |
| 1999 Q2 | 82.38 Million ILS | 0.94% |
| 1999 Q1 | 81.62 Million ILS | 259018.16% |
| 1999 Q4 | 75.97 Million ILS | -11.96% |
| 1999 FY | 35.72 Million ILS | 8486.03% |
| 1998 Q2 | 367.05 Thousand ILS | 1.89% |
| 1998 FY | 416.05 Thousand ILS | -99.94% |
| 1998 Q1 | 360.25 Thousand ILS | -99.93% |
| 1998 Q4 | 31.5 Thousand ILS | -91.81% |
| 1998 Q3 | 384.55 Thousand ILS | 4.77% |
| 1997 FY | 679.45 Million ILS | -1.29% |
| 1997 Q1 | 374.12 Million ILS | -27.66% |
| 1997 Q4 | 512.27 Million ILS | 25.83% |
| 1997 Q2 | 447.75 Million ILS | 19.68% |
| 1997 Q3 | 407.1 Million ILS | -9.08% |
| 1996 Q2 | 389.57 Million ILS | 3.18% |
| 1996 FY | 688.37 Million ILS | 0.0% |
| 1996 Q3 | 411.81 Million ILS | 5.71% |
| 1996 Q1 | 377.58 Million ILS | 0.0% |
| 1996 Q4 | 517.15 Million ILS | 25.58% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AVITA Medical, Inc. | 41.68 Million USD | 99.213% |
| Manhattan Scientifics, Inc. | -1000.00 USD | 32900.0% |
| Össur hf. | 485.57 Million USD | 99.932% |
| QHSLab, Inc. | 793.6 Thousand USD | 58.67% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | 99.932% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 5.14 Million USD | 93.626% |
| Aurora Spine Corporation | 8.21 Million USD | 96.006% |
| BrainsWay Ltd. | 23.09 Million USD | 98.58% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 466.38 Thousand USD | 29.672% |
| Hamilton Thorne Ltd. | 35.08 Million USD | 99.065% |
| Vivos Inc. | -6036.00 USD | 5534.062% |
| Kelyniam Global, Inc. | 2.03 Million USD | 83.891% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 143.344% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 267.929% |
| Avitar, Inc. | 836.7 Thousand USD | 60.798% |
| Nanomix Corporation | -69.45 Thousand USD | 572.228% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | 98.041% |
| Theraclion SA | -1.08 Million USD | 130.36% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -353.46 Thousand USD | 192.796% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | 68.628% |
| Lombard Medical, Inc. | 955 Thousand USD | 65.654% |
| ALR Technologies Inc. | 4945.00 USD | -6532.963% |
| Stratec SE | 71.58 Million USD | 99.542% |
| Vycor Medical, Inc. | 1.31 Million USD | 75.069% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 532.09 Million USD | 99.938% |
| VMS Rehab Systems, Inc. | -10.44 USD | 3141862.452% |
| NewCardio, Inc. | 105.1 Thousand USD | -212.075% |
| Guided Therapeutics, Inc. | 36 Thousand USD | -811.111% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | -22.125% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | -479.567% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | 44.175% |
| SANUWAVE Health, Inc. | 14.36 Million USD | 97.716% |
| IR-Med Inc. | -17 Thousand USD | 2029.412% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -58.9% |
| Polarean Imaging plc | 335.48 Thousand USD | 2.231% |
| United American Healthcare Corporation | -8000.00 USD | 4200.0% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 2642.636% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | 70.02% |
| Medical Supply International USA, Inc. | 1.75 Million USD | 81.35% |
| Urologix, Inc. | 6.09 Million USD | 94.617% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 203.571% |
| SS Innovations International, Inc. | 713.44 Thousand USD | 54.026% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | 99.992% |
| NIOX Group Plc | 28.13 Million USD | 98.834% |
| Fuse Medical, Inc. | 10.73 Million USD | 96.944% |
| Broncus Holding Corporation | 7.22 Million USD | 95.461% |
| Brain Scientific Inc. | 54.32 Thousand USD | -503.774% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | 58.978% |
| Health Logic Interactive Inc. | - USD | -Infinity% |